a deal with big pharma is just selling off the farm or part of it to then have enough cash to sell a drug or 3. So it’s not really the biggest catalyst. The biggest catalyst in my view is efficacy, ( say half) and then drug approval …. And then that validates the platform. Worth another 3x those 2 combined. It’s just a matter of who values what when, but 4BUS for4 4 drugs in clinic is not a stretch at all. That’s 60x our mcap as of today.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.045(3.13%) |
Mkt cap ! $813.6M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.46 | $1.36 | $314.1K | 222.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 330 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 12708 | 2 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |